Advance on the diagnostic potential of biological markers in the early detection of Alzheimer Disease

被引：1

作者：

Borroni, B ^{[1
]}

DiLuca, M

Cattabeni, F

Padovani, A

机构：

[1] Univ Brescia, Dept Neurol Sci, Brescia, Italy

[2] Univ Milan, Inst Pharmacol Sci, Milan, Italy

来源：

NEUROSCIENCE RESEARCH COMMUNICATIONS | 2004年 / 35卷 / 03期

关键词：

Alzheimer Disease; Mild Cognitive Impairment; biomarkers; Amyloid Precursor Protein; CSF; Abeta; Tau; platelets;

D O I：

10.1002/nrc.20036

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Here we summarise current knowledge about biological markers available for early Alzheimer Disease detection. In fact delineating disease process from "normal ageing" may be difficult in the very early stages; in later stages of the disease distinguishing Dementia of Alzheimer Type from a number of neurodegenerative diseases associated with dementia may also be troublesome.

引用

收藏

页码：232 / 245

页数：14

相关论文

共 70 条

[1]

Alzheimers Assoc, 1998, NEUROBIOL AGING, V19, P109

[2] Cerebrospinal fluid β-amyloid(1-42) in Alzheimer disease -: Differences between early- and late-onset Alzheimer disease and stability during the course of disease [J].

Andreasen, N ;

Hesse, C ;

Davidsson, P ;

Minthon, L ;

Wallin, A ;

Winblad, B ;

Vanderstichele, H ;

Vanmechelen, E ;

Blennow, K .

ARCHIVES OF NEUROLOGY, 1999, 56 (06) :673-680

[3] Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice [J].

Andreasen, N ;

Minthon, L ;

Davidsson, P ;

Vanmechelen, E ;

Vanderstichele, H ;

Winblad, B ;

Blennow, K .

ARCHIVES OF NEUROLOGY, 2001, 58 (03) :373-379

[4] Platelet APP isoform ratios correlate with declining cognition in AD [J].

Baskin, F ;

Rosenberg, RN ;

Iyer, L ;

Hynan, L ;

Cullum, CM .

NEUROLOGY, 2000, 54 (10) :1907-1909

[5] Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients [J].

Baskin, F ;

Rosenberg, RN ;

Fang, X ;

Hynan, LS ;

Moore, CB ;

Weiner, M ;

Vega, GL .

NEUROLOGY, 2003, 60 (12) :2006-2007

[6] NONNEURAL MARKERS IN ALZHEIMER-DISEASE [J].

BLASS, JP ;

GIBSON, GE .

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1992, 6 (04) :205-224

[7] CSF markers for incipient Alzheimer's disease [J].

Blennow, K ;

Hampel, H .

LANCET NEUROLOGY, 2003, 2 (10) :605-613

[8] Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia Alzheimer type - A 2-year follow-up study [J].

Borroni, B ;

Colciaghi, F ;

Caltagirone, C ;

Rozzini, L ;

Broglio, L ;

Cattabeni, F ;

Di Luca, M ;

Padovani, A .

ARCHIVES OF NEUROLOGY, 2003, 60 (12) :1740-1744

[9] Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms [J].

Borroni, B ;

Colciaghi, F ;

Corsini, P ;

Akkawi, N ;

Rozzini, L ;

Del Zotto, E ;

Talarico, G ;

Cattabeni, F ;

Lenzi, GL ;

Di Luca, M ;

Padovani, A .

NEUROLOGICAL SCIENCES, 2002, 23 (05) :207-210

[10] Amyloid precursor protein in platelets of patients with Alzheimer disease -: Effect of acetylcholinesterase inhibitor treatment [J].

Borroni, B ;

Colciaghi, F ;

Pastorino, L ;

Pettenati, C ;

Cottini, E ;

Rozzini, L ;

Monastero, R ;

Lenzi, GL ;

Cattabeni, F ;

Di Luca, M ;

Padovani, A .

ARCHIVES OF NEUROLOGY, 2001, 58 (03) :442-446

← 1 2 3 4 5 6 7 →